Michelle Bound

Ms Michelle Bound

Senior Research Officer

School of Medicine

College of Health


Date Position Institution name
2009 - ongoing Senior Research Officer University of Adelaide

Date Institution name Country Title
2007 - 2009 University of South Australia Australia Bachelor of Medical Radiations (Nuclear Medicine)
1997 - 1999 University of South Australia Australia Diploma in Business Management (IR/HRM)

Date Title Institution name Country
1995 OHS&W Certificate 1, 2 & 3 Trade Union Training Authority Australia
1991 Certificate in Small Business Management TAFE Australia

Year Citation
2025 Xie, C., Iroga, P., Bound, M. J., Grivell, J., Huang, W., Jones, K. L., . . . Wu, T. (2025). Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes. Diabetes Obesity and Metabolism, 27(3), 1614-1617.
DOI Scopus2 WoS2
2025 Quast, D. R., Xie, C., Bound, M. J., Grivell, J., Hatzinikolas, S., Jones, K. L., . . . Wu, T. (2025). Effects of metformin on postprandial blood pressure, heart rate, gastric emptying, GLP-1 and the prevalence of postprandial hypotension in type 2 diabetes - a double-blind, placebo-controlled crossover study.. Diabetes, 74(4), 611-618.
DOI Scopus8 WoS7 Europe PMC5
2025 Borg, M. J., Xie, C., Chen, C., Bound, M. J., Grivell, J., Huang, W., . . . Wu, T. (2025). Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration. Diabetes Obesity and Metabolism, 27(9), 5370-5372.
DOI Scopus1 WoS1 Europe PMC2
2024 Quast, D. R., Lancaster, D., Xie, C., Bound, M. J., Grivell, J., Jones, K. L., . . . Nauck, M. A. (2024). Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes. Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 26(9), 3897-3905.
DOI Scopus1 WoS1 Europe PMC1
2024 Xie, C., Iroga, P., Bound, M. J., Grivell, J., Huang, W., Jones, K. L., . . . Wu, T. (2024). Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study. Diabetologia, 67(7), 1260-1270.
DOI Scopus18 WoS16 Europe PMC16
2024 Jalleh, R. J., Phillips, L., Umapathysivam, M. M., Jones, K. L., Marathe, C. S., Watson, L. E., . . . Horowitz, M. (2024). Gastric emptying during and following resolution of moderate diabetic ketoacidosis in type 1 diabetes: a case series. BMJ Open Diabetes Research & Care, 12(2), e003854-1-e003854-4.
DOI Scopus1 WoS1 Europe PMC1
2021 Rayner, C. K., Watson, L. E., Phillips, L. K., Lange, K., Bound, M. J., Grivell, J., . . . Natali, A. (2021). Erratum to: Effects of sustained treatment with lixisenatide on gastric emptying and postprandial glucose metabolism in type 2 diabetes: A randomized controlled trial (Diabetes Care 2020, 43, 1813–1821). Diabetes Care, 44(1), 297.
DOI Scopus1 WoS1
2020 Rayner, C. K., Watson, L. E., Phillips, L. K., Lange, K., Bound, M. J., Grivell, J., . . . Natali, A. (2020). Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.. Diabetes Care, 43(8), 1813-1821.
DOI Scopus44 WoS45 Europe PMC43
2019 Watson, L. E., Phillips, L. K., Wu, T., Bound, M. J., Jones, K. L., Horowitz, M., & Rayner, C. K. (2019). Longitudinal evaluation of gastric emptying in type 2 diabetes. Diabetes Research and Clinical Practice, 154, 27-34.
DOI Scopus12 WoS10 Europe PMC7
2019 Riceman, M. D., Bound, M., Grivell, J., Hatzinikolas, S., Piotto, S., Nguyen, N. Q., . . . Phillips, L. K. (2019). The prevalence and impact of low faecal elastase-1 in community-based patients with type 2 diabetes. Diabetes Research and Clinical Practice, 156(107822), 107822-1-107822-9.
DOI Scopus6 WoS5 Europe PMC3
2019 Borg, M. J., Bound, M., Grivell, J., Sun, Z., Jones, K. L., Horowitz, M., . . . Wu, T. (2019). Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes. Diabetes, Obesity and Metabolism, 21(3), 640-647.
DOI Scopus46 WoS44 Europe PMC40
2019 Watson, L. E., Phillips, L. K., Wu, T., Bound, M. J., Checklin, H. L., Grivell, J., . . . Rayner, C. K. (2019). A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: a 12-week, single-blind, randomized, placebo-controlled trial. Diabetes, Obesity and Metabolism, 21(4), 930-938.
DOI Scopus55 WoS53 Europe PMC45
2019 Watson, L. E., Phillips, L. K., Wu, T., Bound, M. J., Checklin, H., Grivell, J., . . . Rayner, C. K. (2019). Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetes. Clinical Nutrition, 38(6), 2827-2832.
DOI Scopus30 WoS28 Europe PMC25
2019 Zhang, X., Young, R. L., Bound, M., Hu, S., Jones, K. L., Horowitz, M., . . . Wu, T. (2019). Comparative effects of proximal and distal small intestinal glucose exposure on glycemia, incretin hormone secretion, and the incretin effect in health and type 2 diabetes. Diabetes Care, 42(4), 520-528.
DOI Scopus50 WoS47 Europe PMC40
2018 Veedfald, S., Wu, T., Bound, M., Grivell, J., Hartmann, B., Rehfeld, J. F., . . . Rayner, C. K. (2018). Hyperosmolar duodenal saline infusion lowers circulating ghrelin and stimulates intestinal hormone release in young men. Journal of Clinical Endocrinology and Metabolism, 103(12), 4409-4418.
DOI Scopus20 WoS21 Europe PMC17
2017 Thazhath, S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., . . . Rayner, C. K. (2017). Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes. Diabetes and Vascular Disease Research, 14(1), 59-63.
DOI Scopus16 WoS14 Europe PMC12
2017 Marathe, C., Rayner, C., Lange, K., Bound, M., Wishart, J., Jones, K., . . . Horowitz, M. (2017). Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance. Physiological Reports, 5(4), e13122-1-e13122-6.
DOI Scopus12 WoS11 Europe PMC10
2017 Wu, T., Trahair, L., Little, T., Bound, M., Zhang, X., Wu, H., . . . Jones, K. (2017). Effects of vildagliptin and metformin on blood pressure and heart rate responses to small intestinal glucose in type 2 diabetes.. Diabetes Care, 40(5), 702-705.
DOI Scopus17 WoS17 Europe PMC10
2016 Thazhath, S., Marathe, C., Wu, T., Chang, J., Khoo, J., Kuo, P., . . . Rayner, C. (2016). The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial. Diabetes, 65(1), 269-275.
DOI Scopus74 WoS72 Europe PMC68
2016 Thazhath, S., Wu, T., Bound, M., Checklin, H., Standfield, S., Jones, K., . . . Rayner, C. (2016). Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. American Journal of Clinical Nutrition, 103(1), 66-70.
DOI Scopus105 WoS102 Europe PMC86
2016 Thazhath, S., Wu, T., Bound, M., Checklin, H., Standfield, S., Jones, K., . . . Rayner, C. (2016). Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: a randomised controlled trial. Nutrition, 32(5), 553-559.
DOI Scopus10 WoS10 Europe PMC8
2016 Wu, T., Little, T., Bound, M., Borg, M., Zhang, X., Deacon, C., . . . Rayner, C. (2016). A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes. Diabetes Care, 39(4), 511-517.
DOI Scopus91 WoS89 Europe PMC76
2016 Marathe, C., Horowitz, M., Trahair, L., Bound, M., Checklin, H., Lange, K., . . . Jones, K. (2016). Effect of duodenal glucose load on blood pressure in type 2 diabetes. Diabetes Research and Clinical Practice, 113, 38-40.
DOI Scopus3 WoS4 Europe PMC3
2016 Marathe, C. S., Rayner, C. K., Lange, K., Bound, M., Wishart, J. M., Jones, K. L., & Horowitz, M. (2016). Relationships of early insulin response and oral disposition index with gastric emptying during an oral glucose tolerance test in subjects with normal glucose tolerance. DIABETIC MEDICINE, 33, 15.
2016 Wu, T., Zhang, X., Trahair, L., Bound, M., Little, T., Deacon, C., . . . Rayner, C. (2016). Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 101(12), 4769-4778.
DOI Scopus17 WoS17 Europe PMC16
2015 Marathe, C. S., Bound, M., Lange, K., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015). Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in health. Acta Diabetologica, 52(4), 817-819.
DOI Scopus2 WoS2 Europe PMC2
2015 Wu, T., Trahair, L., Bound, M., Deacon, C., Horowitz, M., Rayner, C., & Jones, K. (2015). Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?. Diabetic Medicine, 32(5), 595-600.
DOI Scopus7 WoS6 Europe PMC5
2015 Wu, T., Thazhath, S., Marathe, C., Bound, M., Jones, K., Horowitz, M., & Rayner, C. (2015). Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy males. Nutrition and Diabetes, 5(5, article no. e156), e156-1-e156-4.
DOI Scopus47 WoS70 Europe PMC18
2015 Marathe, C., Horowitz, M., Trahair, L., Wishart, J., Bound, M., Lange, K., . . . Jones, K. (2015). Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance test. Journal of Clinical Endocrinology and Metabolism, 100(9), 3565-3571.
DOI Scopus82 WoS78 Europe PMC65
2014 Thazhath, S., Wu, T., Bound, M., Checklin, H., Jones, K., Willoughby, S., . . . Rayner, C. (2014). Changes in meal composition and duration affect postprandial endothelial function in healthy humans. American Journal of Physiology. Gastrointestinal and Liver Physiology, 307(12), G1191-G1197.
DOI Scopus10 WoS10 Europe PMC8
2014 Wu, T., Thazhath, S., Bound, M., Jones, K., Horowitz, M., & Rayner, C. (2014). Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?. Diabetes Research and Clinical Practice, 106(1), e3-e6.
DOI Scopus61 WoS58 Europe PMC54
2014 Marathe, C., Rayner, C., Bound, M., Checklin, H., Standfield, S., Wishart, J., . . . Horowitz, M. (2014). Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes. Diabetes, 63(8), 2668-2675.
DOI Scopus48 WoS43 Europe PMC41
2014 Wu, T., Ma, J., Bound, M., Checklin, H., Deacon, C., Jones, K., . . . Rayner, C. (2014). Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin. Diabetes, 63(8), 2776-2787.
DOI Scopus48 WoS48 Europe PMC41
2013 Wu, T., Bound, M., Standfield, S., Bellon, M., Young, R., Jones, K., . . . Rayner, C. (2013). Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans. Diabetes Care, 36(12), e202-e203.
DOI Scopus52 WoS53 Europe PMC48
2013 Wu, T., Bound, M., Zhao, R., Standfield, S., Bellon, M., Jones, K., . . . Rayner, C. (2013). Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes. Diabetes Care, 36(7), 1913-1918.
DOI Scopus53 WoS52 Europe PMC48
2013 Wu, T., Bound, M., Standfield, S., Jones, K., Horowitz, M., & Rayner, C. (2013). Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans. Journal of Clinical Endocrinology and Metabolism, 98(4), 718-722.
DOI Scopus80 WoS74 Europe PMC68
2013 Wu, T., Bound, M., Standfield, S., Gedulin, B., Jones, K., Horowitz, M., & Rayner, C. (2013). Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. Diabetes Obesity & Metabolism, 15(5), 474-477.
DOI Scopus116 WoS113 Europe PMC98
2012 Chang, J., Russo, A., Bound, M., Rayner, C., Jones, K., & Horowitz, M. (2012). A 25-year longitudinal evaluation of gastric emptying in diabetes. Diabetes Care, 2012(12), 1-3.
DOI Scopus49 WoS41 Europe PMC39
2012 Wu, T., Zhao, R., Bound, M., Checklin, H., Bellon, M., Little, T., . . . Rayner, C. (2012). Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans. American Journal of Clinical Nutrition, 95(1), 78-83.
DOI Scopus147 WoS140 Europe PMC115

Year Citation
2024 Xie, C., Li, T., Bound, M., Grivell, J., Sun, Y., Jones, K. L., . . . Wu, T. (2024). Effects of well and poorly absorbed low-calorie sweeteners on insulin secretion and sensitivity in type 2 diabetes. In DIABETOLOGIA Vol. 67 (pp. S328). SPAIN, Madrid: SPRINGER.
2024 Sun, Y., Xie, C., Bound, M., Jones, K. L., Horowitz, M., Young, R., . . . Wu, T. (2024). Disparities in GLP-1 and GIP responses to small intestinal glucose infusion between people with well- and poorly-controlled type 2 diabetes. In DIABETOLOGIA Vol. 67 (pp. S92). SPAIN, Madrid: SPRINGER.
2022 Lu, A., Bound, M., Wu, T., Blefari, C., Horowitz, M., Rayner, C., & Jones, K. (2022). The effect of eight weeks' treatment with the short-acting GLP-1 agonist, lixisenatide, on postprandial blood pressure and heart rate in patients with type two diabetes - A secondary quantitative study. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39-40). WILEY.
2022 Quast, D. R., Xie, C., Bound, M. J., Grivell, J., Jones, K. L., Horowitz, M., . . . Wu, T. (2022). Effects of acute and sub-chronic treatment with metformin on post-prandial blood pressure and heart rate in diet-controlled type 2 diabetes. In DIABETOLOGIA Vol. 65 (pp. S319-S320). Stockholm, SWEDEN: SPRINGER.
2018 Rayner, C. K., Watson, L. E., Phillips, L. K., Bound, M. J., Grivell, J., Wu, T., . . . Natali, A. (2018). Effects of sustained treatment with lixisenatide on gastric emptying and glucose metabolism in type 2 diabetes. In DIABETOLOGIA Vol. 61 (pp. S386-S387). GERMANY, Berlin: SPRINGER.
2015 Marathe, C., Horowitz, M., Bound, M., Jones, K. L., & Rayner, C. K. (2015). Relationships of early and late glycaemic responses with gastric emptying during an oral glucose tolerance test. In Diabetes. Adelaide.
2014 Marathe, C., Bound, M., Standfield, S., Wishart, J., Jones, K. L., Horowitz, M., & Rayner, C. K. (2014). Ethnic Variation in the Secretion of Insulin and Incretin Hormones Following Intraduodenal Glucose Infusion in Healthy Humans. In DIABETES Vol. 63 (pp. A456). AMER DIABETES ASSOC.
2013 Marathe, C., Rayner, C., Bound, M., Checklin, H., Standfield, S., Jones, K. L., & Horowitz, M. (2013). The Size of the Incretin Effect Is Dependent on the Rate of Small Intestinal Glucose Entry in Type 2 Diabetes. In DIABETES Vol. 62 (pp. A474). AMER DIABETES ASSOC.
2013 Thazhath, S. S., Bound, M. J., Jones, K., Horowitz, M., & Rayner, C. (2013). Effect of Hydroxycitric Acid on the Glycemic Response to a Small Intestinal Glucose Load in Healthy Humans. In GASTROENTEROLOGY Vol. 144 (pp. S473). FL, Orlando: W B SAUNDERS CO-ELSEVIER INC.
2013 Marathe, C., Feinle-Bisset, C., Bound, M., Standfield, S., Jones, K. L., Horowitz, M., & Rayner, C. (2013). Effect of Rate of Duodenal Glucose Delivery on the "Oral" Disposition Index in Health and Type 2 Diabetes. In DIABETES Vol. 62 (pp. A479). AMER DIABETES ASSOC.
2012 Bound, M., Wu, T., Gedulin, B., Horowitz, M., & Rayner, C. (2012). Effects of bile acid enemas on GLP-1 and PYY secretion in healthy humans. In Diabetologia Vol. 55 (pp. S338). Germany: Springer.
DOI
2011 Wu, T., Zhao, B., Bound, M., Checklin, H. L., Bellon, M., Little, T. J., . . . Rayner, C. K. (2011). Effects of different sweet preloads on incretin hormone responses, gastric emptying and postprandial glycaemia in healthy humans. In DIABETOLOGIA Vol. 54 (pp. S330). Lisbon, PORTUGAL: SPRINGER.
2010 Wu, T., Zhao, B., Bound, M., Checklin, H. L., Bellon, M., Little, T., . . . Rayner, C. K. (2010). Effects of sweet preloads on gastric emptying and postprandial glycaemia in healthy subjects. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 25 (pp. A105). WILEY-BLACKWELL PUBLISHING, INC.

Year Citation
2023 Veedfald, S., Sun, Y., Xiang, C., Xie, C., Wu, T., Bound, M., . . . Rayner, C. K. (2023). Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 do not account for the entire incretin effect in healthy humans. Poster session presented at the meeting of Abstracts of the 59 th EASD Annual Meeting of the European Association for the Study of Diabetes, as published in Diabetologia. Hamburg, Germany: Springer.
DOI WoS1
2023 Wu, T., Xie, C., Iroga, P., Bound, M., Grivell, J., Huang, W., . . . Rayner, C. (2023). The impact of timing of metformin administration on glycaemic and glucagon like peptide 1 responses to intraduodenal glucose in type 2 diabetes. Poster session presented at the meeting of DIABETOLOGIA. GERMANY, Hamburg: SPRINGER.
2023 Quast, D. R., Lancaster, D., Xie, C., Bound, M. J., Grivell, J., Jones, K. L., . . . Nauck, M. A. (2023). Glucagon-like peptide 1 for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes: a systematic comparison of intravenous and subcutaneous routes. Poster session presented at the meeting of DIABETOLOGIA. GERMANY, Hamburg: SPRINGER.
2023 Xie, C., Huang, W., Bound, M., Grivell, J., Jones, K., Horowitz, M., . . . Wu, T. (2023). Effect of intestinal exposure to endogenous bile acids on the incretin axis in type 2 diabetes. Poster session presented at the meeting of DIABETOLOGIA. GERMANY, Hamburg: SPRINGER.
2020 Xie, C., Wang, X., Bound, M. J., Young, R. L., Jones, K. L., Horowitz, M., . . . Wu, T. (2020). Bitter taste signalling modulates bile acid-induced PYY, but not GLP-1 secretion in healthy humans. Poster session presented at the meeting of Abstracts of the 56th Annual Meeting of the European Association for the Study of Diabetes (EASD), as published in Diabetologia. Virtual Online: Springer-Verlag.
DOI
2020 Wu, T., Xie, C., Wang, X., Bound, M. J., Grivell, J., Jones, K. L., . . . Rayner, C. K. (2020). Role of endogenous glucagon-like peptide-1 in the serum triglyceride response to intraduodenal fat infusion in type 2 diabetic patients on vildagliptin. Poster session presented at the meeting of DIABETOLOGIA. ELECTR NETWORK: SPRINGER.
2020 Sansome, D. J., Veedfald, S., Xie, C., Bound, M., Grivell, J., Jones, K. L., . . . Wu, T. (2020). Role of bile acids on glucose-lowering by metformin in type 2 diabetes. Poster session presented at the meeting of DIABETOLOGIA. ELECTR NETWORK: SPRINGER.
2020 Bizzotto, R., Rayner, C. K., Watson, L. E., Phillips, L. K., Lange, K., Bound, M. J., . . . Mari, A. (2020). Comparison of paracetamol absorption and gastric emptying measured by scintigraphy in relation to rate of appearance of oral glucose and postprandial glycaemia. Poster session presented at the meeting of DIABETOLOGIA. ELECTR NETWORK: SPRINGER.
2019 Xie, C., Wang, X., Bound, M. J., Grivell, J., Jones, K. L., Horowitz, M., . . . Wu, T. (2019). Roles of endogenous GLP-1 in the glycaemic and energy expenditure responses to fat in type 2 diabetes studied using vildagliptin and exendin(9-39). Poster session presented at the meeting of DIABETOLOGIA. Barcelona, SPAIN: SPRINGER.
2019 Horowitz, M., Xie, C., Wang, X., Bound, M. J., Grivell, J., Jones, K. L., . . . Wu, T. (2019). Comparative effects of intraduodenal glucose and fat on blood pressure and heart rate in type 2 diabetes. Poster session presented at the meeting of Abstracts of the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), as published in Diabetologia. Barcelona, SPAIN: Springer-Verlag.
DOI Europe PMC13
2018 Veedfald, S., Wu, T., Bound, M., Grivell, J., Hartmann, B., Rehfeld, J. F., . . . Rayner, C. K. (2018). Hyperosmolar duodenal saline infusion lowers circulating ghrelin and stimulates intestinal hormone release in young men. Poster session presented at the meeting of NEUROGASTROENTEROLOGY AND MOTILITY. WILEY.
2018 Wu, T., Borg, M., Jones, K. L., Horowitz, M., & Rayner, C. K. (2018). Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and GLP-1, and gastric emptying after oral glucose in type 2 diabetes. Poster session presented at the meeting of DIABETOLOGIA. Berlin, GERMANY: SPRINGER.
2018 Xie, C., Wang, X., Bound, M. J., Grivell, J., Young, R. L., Jones, K. L., . . . Wu, T. (2018). Effects of the bitter taste receptor agonist, denatonium benzoate, on postprandial glycaemia, gastric emptying and energy intake in type 2 diabetes. Poster session presented at the meeting of Abstracts of the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), as published in Diabetologia. Berlin Heidelberg: Springer.
DOI Europe PMC9
2018 Young, R. L., Kreuch, D., Mobegi, F. M., Leong, L., Schober, G., Isaacs, N. J., . . . Rogers, G. B. (2018). Low-calorie sweeteners disrupt the gut microbiome in healthy subjects in association with impaired glycaemic control. Poster session presented at the meeting of Abstracts of the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), as published in Diabetologia. Berlin Heidelberg: Springer.
DOI
2017 Phillips, L., Watson, L., Wu, T., Bound, M., Checklin, H., Grivell, J., . . . Rayner, C. (2017). Longitudinal evaluation of gastric emptying in type 2 diabetes. Poster session presented at the meeting of Abstracts of the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), as published in Diabetologia. Berlin Heidelberg: Springer.
DOI
2017 Young, R., Isaacs, N., Schober, G., Wu, T., Cvijanovic, N., Pezos, N., . . . Horowitz, M. (2017). Impact of artificial sweeteners on glycaemic control in healthy humans. Poster session presented at the meeting of Abstracts of the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), as published in Diabetologia. Berlin Heidelberg: Springer.
DOI WoS4
2017 Rayner, C., Wu, T., Horowitz, M., & Jones, K. (2017). Blockade of glucagon-like peptide-1 receptors by exendin(9-39) attenuates the increase in heart rate during small intestinal glucose infusion in type 2 diabetes. Poster session presented at the meeting of Abstracts of the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), as published in Diabetologia. Berlin Heidelberg: Springer.
DOI WoS1
2016 Zhang, X., Bound, M., Standfield, S., Hu, S., Jones, K., Horowitz, M., . . . Wu, T. (2016). Comparative effects of proximal and distal small intestinal glucose on glycaemia, incretin hormone secretion and incretin effect in healthy males. Poster session presented at the meeting of Abstracts of the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD), as published in Diabetologia. Munich, GERMANY: Springer-Verlag.
DOI WoS2
2016 Wu, T., Zhang, X., Little, T. L., Bound, M. J., Standfield, S., Deacon, C. F., . . . Rayner, C. K. (2016). The rate of intraduodenal glucose delivery affects the lowering of blood glucose by vildagliptin in type 2 diabetes. Poster session presented at the meeting of DIABETOLOGIA. Munich, GERMANY: SPRINGER.
2016 Mignone, L., Wu, T., Phillips, L., Bound, M., Checklin, H., Grivell, J., . . . Rayner, C. (2016). A whey/guar "preload" improves postprandial glycaemia and HbA(1c) in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trial. Poster session presented at the meeting of Abstracts of the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD), as published in Diabetologia. Munich, GERMANY: Springer-Verlag.
DOI
2016 Phillips, L. K., Marathe, C., Trahair, L., Bound, M. J., Hatzinikolas, S., Mignone, L. E., . . . Horowitz, M. (2016). Preliminary observations of gastric emptying in diabetic ketoacidosis. Poster session presented at the meeting of DIABETOLOGIA. Munich, GERMANY: SPRINGER.
2015 Marathe, C. S., Rayner, C. K., Bound, M., Checklin, H., Standfield, S., Wishart, J., . . . Horowitz, M. (2015). SMALL INTESTINAL GLUCOSE EXPOSURE DETERMINES THE MAGNITUDE OF THE INCRETIN EFFECT IN HEALTH AND TYPE 2 DIABETES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
DOI
2014 Mignone, L. E., Wu, T., Bound, M. J., Jones, K. L., Horowitz, M., & Rayner, C. K. (2014). A low-dose whey protein preload slows gastric emptying and improves post-prandial glycaemia in type 2 diabetes. Poster session presented at the meeting of DIABETOLOGIA. SPRINGER.
2014 Wu, T., Bound, M., Deacon, C., Jones, K., Horowitz, M., & Rayner, C. (2014). Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?. Poster session presented at the meeting of DIABETOLOGIA. SPRINGER.
2013 Thazhath, S. S., Bound, M., Jones, K., Horowitz, M., & Rayner, C. (2013). Effect of hydroxycitric acid on the glycaemic response to a small intestinal glucose load in healthy humans. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.

Connect With Me

External Profiles

Other Links